Update for Investors of

TATAELXSI

is currently trading at Rs. 5840.00, up by 283.10 points or 5.09% from its previous closing of Rs. 5556.90 on the BSE. The scrip opened at Rs. 5597.45 and has touched a high and low of Rs. 5863.40 and Rs. 5597.45 respectively. So far 60682 shares were traded on the counter. The promoters holding in the company stood at 43.91%, while Institutions and Non-Institutions held 22.54% and 33.55% respectively. Tata Elxsi has inaugurated ‘Bayer Development Centre in Radiology’ at Tata Elxsi, Pune, India. The centre is designed to co-develop with Bayer, a leader in key areas of Radiology, advanced radiology devices and technology that enable early and accurate diagnosis and treatment of critical illnesses, supporting Bayer’s global mission to bring innovative, safe, and compliant solutions to patients and clinical staff worldwide. This centre will provide a wide range of engineering for complex radiology devices, with an initial focus on Molecular Imaging. The facility’s integrated approach, which combines design, development, and validation, the centre will help accelerate time-to-market, enhance cost efficiency, and help deliver new technology to market fast, efficiently, and at an optimized cost, while meeting highest regulatory compliance standards. This collaboration leverages Tata Elxsi’s healthcare engineering expertise and the strength of the Tata and India ecosystems-enabling access to advanced labs, regulatory partnerships, and specialised technology talent. This creates a scalable foundation for innovation and strengthens Bayer’s ability to deliver radiology solutions across multiple geographies, including the US and EU. Tata Elxsi is a global design and technology services company and works with customers across industries such as automotive, broadcast, healthcare and telecom for product and software development.